Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CNSP |
---|---|---|
09:32 ET | 58689 | 0.131 |
09:33 ET | 130661 | 0.1288 |
09:35 ET | 98762 | 0.1275 |
09:37 ET | 190605 | 0.131 |
09:39 ET | 51638 | 0.13 |
09:42 ET | 37623 | 0.1313 |
09:44 ET | 770663 | 0.135 |
09:46 ET | 92627 | 0.1332 |
09:48 ET | 247175 | 0.1306 |
09:50 ET | 8992 | 0.1322 |
09:51 ET | 23335 | 0.1337 |
09:53 ET | 41670 | 0.1324 |
09:55 ET | 40862 | 0.131 |
09:57 ET | 11440 | 0.1319 |
10:00 ET | 170854 | 0.1325 |
10:02 ET | 36661 | 0.1328 |
10:04 ET | 194248 | 0.1331 |
10:06 ET | 84116 | 0.1316 |
10:08 ET | 116674 | 0.1317 |
10:09 ET | 228394 | 0.1304 |
10:11 ET | 37665 | 0.13 |
10:13 ET | 41521 | 0.1313 |
10:15 ET | 66436 | 0.1318 |
10:18 ET | 34656 | 0.1301 |
10:20 ET | 37441 | 0.1323 |
10:22 ET | 94918 | 0.13 |
10:24 ET | 25905 | 0.1291 |
10:26 ET | 94937 | 0.1273 |
10:27 ET | 35497 | 0.1298 |
10:29 ET | 5223 | 0.1297 |
10:31 ET | 13483 | 0.13 |
10:33 ET | 4191 | 0.13 |
10:36 ET | 191 | 0.1293 |
10:38 ET | 48706 | 0.129 |
10:40 ET | 29959 | 0.129 |
10:42 ET | 18088 | 0.1285 |
10:44 ET | 54645 | 0.1284 |
10:45 ET | 23972 | 0.128099 |
10:47 ET | 49667 | 0.1286 |
10:49 ET | 3342 | 0.128216 |
10:51 ET | 11724 | 0.129399 |
10:54 ET | 8523 | 0.1296 |
10:56 ET | 13094 | 0.129 |
10:58 ET | 15681 | 0.1296 |
11:00 ET | 5100 | 0.128116 |
11:02 ET | 3670 | 0.1281 |
11:03 ET | 84534 | 0.126 |
11:05 ET | 14567 | 0.126505 |
11:07 ET | 98699 | 0.1252 |
11:09 ET | 125364 | 0.123536 |
11:12 ET | 254355 | 0.1231 |
11:14 ET | 59965 | 0.1227 |
11:16 ET | 22047 | 0.1237 |
11:18 ET | 26891 | 0.124 |
11:20 ET | 6088 | 0.1247 |
11:21 ET | 129909 | 0.1238 |
11:23 ET | 656595 | 0.1276 |
11:25 ET | 120997 | 0.1288 |
11:27 ET | 163452 | 0.128101 |
11:30 ET | 21464 | 0.1276 |
11:32 ET | 51799 | 0.128589 |
11:34 ET | 124290 | 0.1289 |
11:36 ET | 261510 | 0.1294 |
11:38 ET | 98658 | 0.1291 |
11:39 ET | 172848 | 0.1308 |
11:41 ET | 70941 | 0.1308 |
11:43 ET | 144982 | 0.131387 |
11:45 ET | 113347 | 0.1306 |
11:48 ET | 80242 | 0.1306 |
11:50 ET | 26230 | 0.1306 |
11:52 ET | 53078 | 0.1301 |
11:54 ET | 31911 | 0.1314 |
11:56 ET | 5558 | 0.1307 |
11:57 ET | 7800 | 0.1307 |
11:59 ET | 51730 | 0.1305 |
12:01 ET | 35660 | 0.1303 |
12:03 ET | 47731 | 0.13 |
12:06 ET | 73692 | 0.1299 |
12:08 ET | 1000 | 0.13 |
12:10 ET | 61063 | 0.1291 |
12:12 ET | 1100 | 0.1295 |
12:14 ET | 98121 | 0.1306 |
12:15 ET | 14883 | 0.1306 |
12:17 ET | 2736 | 0.1296 |
12:19 ET | 2290 | 0.1306 |
12:21 ET | 205459 | 0.1311 |
12:24 ET | 72286 | 0.1308 |
12:26 ET | 8550 | 0.1314 |
12:28 ET | 234371 | 0.131401 |
12:30 ET | 86363 | 0.1302 |
12:32 ET | 61259 | 0.1304 |
12:33 ET | 63820 | 0.1319 |
12:35 ET | 13333 | 0.1314 |
12:37 ET | 15334 | 0.131 |
12:39 ET | 23490 | 0.1318 |
12:42 ET | 551 | 0.1318 |
12:44 ET | 3222 | 0.1312 |
12:46 ET | 1150 | 0.1306 |
12:50 ET | 60921 | 0.1293 |
12:51 ET | 200 | 0.130501 |
12:53 ET | 300 | 0.1298 |
12:55 ET | 1400 | 0.1297 |
12:57 ET | 436 | 0.1293 |
01:00 ET | 6500 | 0.1292 |
01:02 ET | 20930 | 0.129 |
01:04 ET | 12544 | 0.1286 |
01:06 ET | 2935 | 0.1294 |
01:08 ET | 278 | 0.1292 |
01:13 ET | 600 | 0.1287 |
01:15 ET | 23453 | 0.129197 |
01:18 ET | 8570 | 0.1292 |
01:20 ET | 8877 | 0.1293 |
01:22 ET | 13275 | 0.1293 |
01:24 ET | 15090 | 0.1292 |
01:26 ET | 111088 | 0.1293 |
01:27 ET | 2125 | 0.1293 |
01:29 ET | 9000 | 0.1294 |
01:31 ET | 8677 | 0.1294 |
01:33 ET | 1400 | 0.1294 |
01:36 ET | 19100 | 0.1297 |
01:38 ET | 1297 | 0.129651 |
01:42 ET | 3090 | 0.1299 |
01:44 ET | 1500 | 0.13 |
01:45 ET | 11060 | 0.1305 |
01:47 ET | 17777 | 0.1305 |
01:49 ET | 1535 | 0.1304 |
01:54 ET | 136139 | 0.1311 |
01:56 ET | 14323 | 0.1317 |
01:58 ET | 495138 | 0.1322 |
02:00 ET | 159540 | 0.1325 |
02:02 ET | 116001 | 0.1305 |
02:03 ET | 136580 | 0.1308 |
02:05 ET | 48999 | 0.131 |
02:07 ET | 23570 | 0.131 |
02:09 ET | 32903 | 0.1298 |
02:12 ET | 7150 | 0.1298 |
02:14 ET | 2884 | 0.1297 |
02:16 ET | 22001 | 0.129 |
02:18 ET | 31803 | 0.128 |
02:20 ET | 12350 | 0.1284 |
02:21 ET | 2000 | 0.1293 |
02:23 ET | 6408 | 0.129 |
02:25 ET | 4268 | 0.1294 |
02:27 ET | 2950 | 0.1285 |
02:30 ET | 112647 | 0.1278 |
02:32 ET | 18019 | 0.1296 |
02:34 ET | 14600 | 0.129481 |
02:36 ET | 1168 | 0.129 |
02:38 ET | 1604 | 0.1282 |
02:39 ET | 222 | 0.129 |
02:41 ET | 2300 | 0.1282 |
02:43 ET | 20500 | 0.1282 |
02:45 ET | 900 | 0.129 |
02:48 ET | 50542 | 0.1268 |
02:50 ET | 2294 | 0.1268 |
02:52 ET | 3500 | 0.1281 |
02:56 ET | 8789 | 0.1275 |
02:57 ET | 664 | 0.127 |
02:59 ET | 60081 | 0.127 |
03:01 ET | 9810 | 0.127 |
03:03 ET | 50579 | 0.1267 |
03:06 ET | 6917 | 0.1274 |
03:08 ET | 19500 | 0.1275 |
03:10 ET | 37450 | 0.128 |
03:12 ET | 5600 | 0.1277 |
03:14 ET | 900 | 0.1273 |
03:15 ET | 7555 | 0.128 |
03:17 ET | 113414 | 0.1279 |
03:19 ET | 147600 | 0.13 |
03:21 ET | 1140 | 0.1291 |
03:24 ET | 200 | 0.129 |
03:26 ET | 50847 | 0.1289 |
03:28 ET | 20970 | 0.128 |
03:30 ET | 200 | 0.128 |
03:32 ET | 10761 | 0.1275 |
03:33 ET | 12200 | 0.128 |
03:35 ET | 35000 | 0.128 |
03:37 ET | 67934 | 0.1275 |
03:39 ET | 180 | 0.12721 |
03:42 ET | 35310 | 0.128 |
03:44 ET | 573 | 0.126146 |
03:46 ET | 4527 | 0.1265 |
03:48 ET | 28301 | 0.1275 |
03:50 ET | 50200 | 0.1274 |
03:51 ET | 71594 | 0.1275 |
03:53 ET | 9250 | 0.1268 |
03:55 ET | 90331 | 0.1265 |
03:57 ET | 78384 | 0.1262 |
04:00 ET | 59173 | 0.1275 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
CNS Pharmaceuticals Inc | 6.3M | 0.0x | --- |
Clearmind Medicine Inc | 6.3M | -0.1x | --- |
Bionomics Ltd | 6.4M | -0.2x | --- |
Enzon Pharmaceuticals Inc | 6.3M | 18.7x | -60.21% |
Brainstorm Cell Therapeutics Inc | 6.5M | -0.4x | --- |
Adial Pharmaceuticals Inc | 6.5M | -0.2x | --- |
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system (CNS). The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and CNS oncology indications, including glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. In addition, the Company is advancing the development of its WP1244/WP1874 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents. The Company is also evaluating the use of WP1244/WP1874 in the treatment of other primary brain and central nervous system cancers, as well as cancers metastatic to the brain including pancreatic, ovarian, and lymphomas.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 49.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.10 |
EPS | $-134.04 |
Book Value | $-35.66 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.